Applied Biosciences Corp.
APPB · OTC
12/31/2019 | 9/30/2019 | 6/30/2019 | 3/31/2019 | |
|---|---|---|---|---|
| Market Cap | $55 | $104 | $110 | $189 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $55 | $104 | $111 | $189 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -30.6% | 15.5% | -9.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 69.7% | 59.7% | 52.8% | 65% |
| EBITDA | -$1 | -$1 | -$0 | -$0 |
| % Margin | -751.5% | -318% | -209% | -67.5% |
| Net Income | -$1 | -$1 | -$0 | -$0 |
| % Margin | -798.1% | -318.4% | -200.5% | -98.8% |
| EPS Diluted | -0.099 | -0.058 | -0.031 | -0.016 |
| % Growth | -71.6% | -88.3% | -88.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |